ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Roche will acquire Innovatis, a privately held German company that specializes in automated cell analysis, especially cell counting, viability testing, and cell function analysis in research and bioproduction. The price of the acquisition is just shy of $20 million. "Innovatis' technology will complement the existing Roche cell analysis portfolio" and is synergistic to the xCELLigence technology that Roche launched in 2008, says Jürgen Schwiezer, CEO of Roche's diagnostics division.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter